Novacyt Takeover. 5 million Yourgene Health Plc agreed to acquire Coastal Genom
5 million Yourgene Health Plc agreed to acquire Coastal Genomics, Inc. Diagnostics firm Novacyt has agreed a takeover of Yourgene, a genomic medicine company based in Manchester, in a deal worth £16. The consideration will be paid as cash consideration of $3 million, $2. Yourgene Health (NIPT:LON): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Yourgene Health | London S. Law firm Stephenson Harwood LLP has advised long-standing diagnostics client Novacyt S. Completion of acquisition of Yourgene Health plc and Board appointments. Jonathan has extensive experience Novacyt shares were very popular on the Paris Bourse on Monday, in the wake of the announcement of the proposed acquisition of Yourgene Health, a British molecular diagnostics Yourgene Health shareholders approved the proposed takeover offer from clinical diagnostics specialist Novacyt , according to a Thursday filing. Premaitha Health plc announced that Peter Collins has stepped down as Chief Business Officer and as a director of the company, effective from 1 November 2018. A. : NIPT | London S. The offer, made through Novacyt UK, secured the Access Novacyt’s AIM Rule 26 information for details on compliance, company structure, and shareholder rights in accordance with regulations. James McCarthy, Acting Group CEO of Novacyt, commented: "The acquisition of Yourgene is an important strategic milestone for Novacyt, broadening the scale and depth of our expertise and a recommended cash offer pursuant to which Novacyt UK Holdings Limited, a wholly owned subsidiary of Novacyt, would acquire the entire issued and to be issued ordinary share capital of Yourgene (the YourGene, a Manchester, England-based molecular diagnostics group, in July agreed to a cash takeover offer from Novacyt that valued the company at around GBP17 million. As part of the agreement, ViaLogy plc will issue 95. The Manchester-based medical diagnostics company said Hextall was stepping Premaitha Health plc Directorate Change Manchester, UK - 4 June 2015: Premaitha Health plc announces the appointment of Barry Hextall, CGMA, MBA, CertIOD Yourgene Health shares were up 12% as of late Tuesday morning trading after it said it conditionally sold its Taiwanese subsidiary to INEX Innovate for up to $4 million. in relation to its recommended takeover of Yourgene Health plc, an international integrated In July, Yourgene Health agreed to a cash takeover offer from Novacyt SA that valued Yourgene at around GBP17 million. 5 million in equity of Yourgene Health PLC shares dropped on Wednesday, after it reported its interim loss widened amid anticipation that revenue in financial year 2023 will fall sharply. 7 million. The IONA Nx seeks to offer clinical labs a high . Premaitha Health Limited entered into an agreement to acquire ViaLogy plc in a reverse merger transaction on June 13, 2014. The sale is conditional on Premaitha Health PLC announced the appointment of Barry Hextall, CGMA, MBA, CertIOD as Chief Financial Officer to the board with immediate effect, replacing Mark Collingbourne. Yourgene Health Plc announced the appointment of Jonathan Seaton to the Board of Directors as a Non-executive Director, with immediate effect. E. Yourgene Health PLC - Manchester, England-based molecular diagnostics group - Reports court-sanctioned scheme of arrangement to facilitate takeover by Novacyt SA has been approved by shareholders at a court and general meeting. Around 99% of shareholders who voted were in favour of the scheme. Mary has Yourgene Health shareholders approved the proposed takeover offer from clinical diagnostics specialist Novacyt , according to a Tuesday filing. Pretax loss in the six months to Yourgene Health PLC said on Friday Chief Financial Officer Barry Hextall was resigning as a director with immediate effect. Acquisition adds scale and diversification to create a stronger global diagnostics business, with a In July, Yourgene Health agreed to a cash takeover offer from Novacyt SA that valued Yourgene at around GBP17 million. Yourgene Health shareholders approved the proposed takeover offer from clinical diagnostics specialist Novacyt , according to a Thursday filing. The offer, made through Novacyt UK, secured the Company Profile Yourgene Health PLC is an integrated molecular diagnostics company. The sale is conditional on Yourgene Health Plc announced the launch of IONA® Nx NIPT workflow, the Company's new innovative non-invasive prenatal test. for $13. Yourgene Health shares were up 12% as of late Tuesday morning trading after it said it conditionally sold its Taiwanese subsidiary to INEX Innovate for up to $4 million. Free real-time prices, and the most active stock market forums in the UK. · Novacyt believes that Yourgene will reach its full potential under Novacyt’s ownership, accelerating revenue growth and building long-term value for the Enlarged Group, driven by the increased Novacyt S. The Company primarily develops, manufactures, and commercializes molecular diagnostic solutions Novacyt share price and NCYT stock charts. has fulfilled its post-acquisition promises following the takeover of Yourgene Health plc, as required by the City Code on Takeovers and Mergers. 5 million on August 4, 2020. Mr. The offer, made through Novacyt UK, Yourgene Health Plc announced the appointment of Mary Tavener as a non-executive director and chair of the audit committee at the company with effect from 25 January 2022.